Risk stratification based on change in plasma Epstein-Barr virus DNA load after treatment in nasopharyngeal carcinoma.

Oncotarget · 2016 · PMC4891061 · PMID 26840023

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

did not reach statistical significanceP = 0.052so close (0.05 < p ≤ 0.1)

Additionally, 3-month-DNA was an independent prognostic factor for DFS (HR, 5.979; 95% CI, 2.429-14.716; P < 0.001) and DMFS (HR, 4.974; 95% CI, 1.704-14.518; P = 0.003); detectable 3-month-DNA was also associated with an increased risk of death, though this trend did not reach statistical significance (HR, 4.772; 95% CI, 0.986-23.090; P = 0.052; Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.